Ensures applicable interactions are aligned with enterprise and medical strategies and ultimately serve to ensure patients have access to BMS medicines through their efforts to ensure the medical community is fully apprised of their safe and effective use. Develops trusted relationships with appropriate academic and community Thought Leaders (TLs) in Immunology through high-quality peer-to-peer scientific dialogue in both proactive and reactive settings. The MSL will use various channels for interactions (1:1, group presentations, virtual, etc.) Medical engagement: - Effectively collaborates and engages in scientific dialogue with TLs to gain insights on clinical landscape to ensure development of a medical plan that is both product/disease area focused and translates into effective launch. - Proactively engages in scientific and clinical conversation to ensure development of a medical plan that is both product/disease area focused and translates into effective launch and Lice Cycle Management (LCM) activities. - Engages with medical societies and PAGs (Patient Advocacy Groups) as appropriate (with Corporate Affairs). - Provides training for external speakers as needed. - Provides medical support to address unsolicited HCP questions in real-time, both in face-to-face interactions and through the Medical on Call virtual capability. - Develops credible connections with key Thought Leaders (TLs) in Immunology through high-quality peer-to-peer scientific dialogue. - Appropriately document and achieve annual goals - Leverages digital capabilities to enhance medical engagement Clinical Trial engagement: - Provides recommendations and insights to clinical development team on study feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and R&D. - Liaises with key large accounts to understand clinical barriers to patient access and ensuring equity in access to clinical trials. - Leads major evidence read-outs with clinical trial investigators e.g., Ph3 top-line data. - Support Interventional and Non-Interventional Research (NIR) studies (e.g. identification and assessment of potential study sites) to facilitate patient recruitment and/or discussions around the safe and effective use of BMS investigational products, as agreed with home office medical and R&D and as defined by the study scope document. - Provide recommendations and insights to clinical development team on study and site feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and R&D. - Support HCPs in the ISR/CSR submission and execution process and study follow-up as agreed upon with home office medical and R&D. - Ensure that BMS Pharmacovigilance procedural documents are understood and applied by investigators of local studies, and alert appropriate BMS personnel to any identified Adverse Events. - Medical Degree, Life Science Degree or equivalent (e.g., MD, PhD, MS, MPH, Pharmacist, etc) scientific or clinical disease area knowledge, patient treatment trends, clinical landscape - Understanding of scientific publications clinical trial design and process understanding of national and regional healthcare and access environment. - Working in a scientific and/or clinical research environment. - Deep understanding of TL environment and needs. Scientific Agility - Has a patient-focused mindset. Customer-focused/enterprise mindset Ability to interpret RWE and identify opportunities for RWE projects. - Be a representative of BMS in all interactions with external stakeholders. - Holds a high level of integrity and good judgment, to navigate the requirements of the role effectively and compliantly in accordance with BMS policies and procedures. The MSL will spend majority of their time in the field with their external customers and additional requirements based on territory assignment and team needs, as needed.